Table 4.
Antropometric, clinical and biochemical characteristics of CHD-free study participants from the 1st and 2nd quartiles of distribution of 15059G>A heteroplasmy level n (%)
| Characteristics |
15059G>A heteroplasmy level1 |
P value | |
| Quartile 1 (n = 38) | Quartile 4 (n = 37) | ||
| Age, yr | 59.4 ± 7.2 | 64.7 ± 8.8 | 0.005 |
| BMI, kg/m2 | 26.0 ± 4.0 | 27.4 ± 5.3 | 0.2 |
| SBP, mmHg | 132 ± 14 | 141 ± 21 | 0.17 |
| DBP, mmHg | 84 ± 11 | 84 ± 10 | 0.99 |
| Cholesterol, mg/dL | 231 ± 41 | 246 ± 47 | 0.14 |
| TG, mg/dL | 106 ± 46 | 147 ± 61 | 0.003 |
| HDL cholesterol, mg/dL | 67 ± 14 | 67 ± 18 | 0.99 |
| LDL cholesterol, mg/dL | 143 ± 37 | 150 ± 42 | 0.44 |
| EH | 15 (39) | 23 (62) | 0.19 |
| LVH | 10 (26) | 10 (27) | 0.98 |
1
Data are mean ± SD. BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; EH: Essential hypertension; LVH: Left ventricular hypertrophy; TG: Triglycerides; HDL: High density lipoproteins; LDL: Low density lipoproteins.